These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3377711)

  • 1. Bioassay of cisplatin and doxorubicin by HeLa cell clonogenic assay.
    Yoshimura T; Iwasaka T; Kidera Y; Sugimori H
    Asia Oceania J Obstet Gynaecol; 1988 Mar; 14(1):123-8. PubMed ID: 3377711
    [No Abstract]   [Full Text] [Related]  

  • 2. Mullerian inhibiting substance reduction of colony growth of human gynecologic cancers in a stem cell assay.
    Fuller AF; Krane IM; Budzik GP; Donahoe PK
    Gynecol Oncol; 1985 Oct; 22(2):135-48. PubMed ID: 3932140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bioassay of cis-diamminedichloroplatinum (II) by human tumor clonogenic assay].
    Sasaki Y; Saijo N; Nomori H; Fujita J; Shimizu E; Kanzawa F; Hoshi A; Takahashi T
    Gan To Kagaku Ryoho; 1984 Oct; 11(10):2274-6. PubMed ID: 6541462
    [No Abstract]   [Full Text] [Related]  

  • 4. Differential sensitivities of human testicular and bladder tumor cell lines to chemotherapeutic drugs.
    Walker MC; Parris CN; Masters JR
    J Natl Cancer Inst; 1987 Aug; 79(2):213-6. PubMed ID: 3474453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-gamma and cytotoxic agents studied in combination using a soft agarose human tumor clonogenic assay.
    Saito T; Berens ME; Welander CE
    Cancer Chemother Pharmacol; 1987; 19(3):233-9. PubMed ID: 3107848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Applications of a human tumour clonogenic cell culture system in gynaecological oncology: review and personal experience.
    Verheijen RH; Herman CJ; Kenemans P
    Eur J Obstet Gynecol Reprod Biol; 1984 Apr; 17(1):43-51. PubMed ID: 6734882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In vitro clonal assay as a predictive test of sensitivity to cytostatics in carcinoma of the human bladder].
    Anton-Aparicio LM; Urmeneta J; Borras M; Balaguer R; Berián JM
    Actas Urol Esp; 1985; 9(6):517-22. PubMed ID: 3938597
    [No Abstract]   [Full Text] [Related]  

  • 8. [Study on chemosensitivity of colony forming cells].
    Morimitus H
    Nihon Hinyokika Gakkai Zasshi; 1990 Feb; 81(2):215-20. PubMed ID: 2325317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Collateral susceptibility of adriamycin-, melphalan- and cisplatin-resistant human ovarian tumor cells to bleomycin.
    Tsuruo T; Hamilton TC; Louie KG; Behrens BC; Young RC; Ozols RF
    Jpn J Cancer Res; 1986 Sep; 77(9):941-5. PubMed ID: 2429947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arsenic compounds induce cytotoxicity and apoptosis in cisplatin-sensitive and -resistant gynecological cancer cell lines.
    Du YH; Ho PC
    Cancer Chemother Pharmacol; 2001 Jun; 47(6):481-90. PubMed ID: 11459200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chemotherapy testing for human ovarian cancer using in vitro colony assay].
    Inoue K
    Gan To Kagaku Ryoho; 1985 Aug; 12(8):1593-8. PubMed ID: 2411225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [In vitro culture of clonogenic cells from various human tumors: chemosensitivity tests].
    Bénard J; Riou G
    Bull Cancer; 1984; 71(4):287-91. PubMed ID: 6093913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Sensitivity of clonogenic cells of human ascitic ovarian cancer to antitumor agents].
    Potapov SL; Korman DB; Shamaev VI; Ershova RB; Makarov OV
    Eksp Onkol; 1987; 9(4):47-50. PubMed ID: 3678125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A murine model to evaluate the ability of in vitro clonogenic assays to predict the response to tumors in vivo.
    Mirabelli CK; Sung CM; McCabe FL; Faucette LF; Crooke ST; Johnson RK
    Cancer Res; 1988 Oct; 48(19):5447-54. PubMed ID: 3046738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term in vitro chemosensitivity testing of tumours of the ovary, cervix and uterus. Measurement of DNA metabolism by 3H thymidine incorporation.
    Khoo SK; Hurst T; Webb MJ; Mackay EV
    Aust N Z J Obstet Gynaecol; 1986 Nov; 26(4):288-94. PubMed ID: 3469997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pt levels following the infusion of daily low-dose cisplatin].
    Hayase R; Yamamoto J; Yamamoto M; Kodama J; Tamada T; Kudoh T
    Gan To Kagaku Ryoho; 1995 Mar; 22(4):565-8. PubMed ID: 7887651
    [No Abstract]   [Full Text] [Related]  

  • 17. A bioassay of cisplatin by human tumor clonogenic assay.
    Sasaki Y; Saijo N; Lee YC; Takahashi H; Ishihara J; Sakurai M; Sano T; Nakano H; Kanzawa F; Hoshi A
    Jpn J Cancer Res; 1986 May; 77(5):494-501. PubMed ID: 3089981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined recombinant human interferon alpha 2 and cytotoxic agents studied in a clonogenic assay.
    Welander CE; Morgan TM; Homesley HD; Trotta PP; Spiegel RJ
    Int J Cancer; 1985 Jun; 35(6):721-9. PubMed ID: 4008100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitivity of clonogenic cells of human ovarian ascitic cancer to antitumor drugs.
    Potapov SL; Korman DB; Shamaev VI; Ershova RB; Makarov OV
    Arch Geschwulstforsch; 1988; 58(2):99-104. PubMed ID: 3377653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CIP2A is associated with multidrug resistance in cervical adenocarcinoma by a P-glycoprotein pathway.
    Liu J; Wang M; Zhang X; Wang Q; Qi M; Hu J; Zhou Z; Zhang C; Zhang W; Zhao W; Wang X
    Tumour Biol; 2016 Feb; 37(2):2673-82. PubMed ID: 26404133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.